{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-003156","form_type":"8-K","ticker":"ADCT","cik":"0001771910","company_name":"ADC Therapeutics SA","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.474374+00:00","generated_at":"2026-06-05T07:09:49.250161+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ADC Therapeutics SA Board approves Annual Bonus Plan for 2024","bullets":["Plan effective retroactively from Jan 1, 2024; bonuses based on corporate objectives approved by Board or Compensation Committee.","Eligible participants: full-time and part-time regular employees in good standing, including named executive officers.","Target bonus expressed as percentage of base salary; payout determined after year-end per payout curve for each objective.","Payment to be made on or before March 15 (US) or end of March (other countries); prorated for new hires, transfers, leaves."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-003156","json":"https://secwatch.observer/filing/0000950103-24-003156.json","markdown":"https://secwatch.observer/filing/0000950103-24-003156.md","text":"https://secwatch.observer/filing/0000950103-24-003156.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771910/000095010324003156/0000950103-24-003156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771910/000095010324003156/dp207290_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T07:09:49.250161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}